Clinical Trial Update: A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of YL202 in Patients With BC [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy, safety, and pharmacokinetics of YL202 in locally advanced or metastatic breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• YL202

Snippet

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. | Conditions: Locally Advanced or Metastatic Breast Cancer | Phase 2 | Status: RECRUITING